Other intangible assets—net
Amgen Other intangible assets—net decreased by 4.0% to $21.38B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 16.9%, from $25.72B to $21.38B. Over 5 years (FY 2020 to FY 2025), Other intangible assets—net shows an upward trend with a 6.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase typically signals recent strategic acquisitions or significant investment in R&D and intellectual property, while a decrease reflects ongoing amortization or potential impairment.
Detailed definition
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software...
Peer comparison
High in semiconductor and tech firms due to heavy reliance on patent portfolios and acquired technology.
non_current_assets_intangible_assets_net_excluding_goodwillHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.31B | $14.66B | $15.18B | $14.57B | $13.93B | $13.27B | $16.08B | $15.39B | $14.63B | $13.15B | $32.64B | $31.37B | $30.17B | $28.92B | $27.70B | $25.72B | $24.61B | $23.14B | $22.28B | $21.38B |
| QoQ Change | — | -4.2% | +3.6% | -4.1% | -4.4% | -4.7% | +21.2% | -4.3% | -4.9% | -10.1% | +148.2% | -3.9% | -3.8% | -4.1% | -4.2% | -7.1% | -4.3% | -6.0% | -3.7% | -4.0% |
| YoY Change | — | — | — | — | -9.0% | -9.5% | +5.9% | +5.7% | +5.1% | -0.9% | +103.0% | +103.8% | +106.2% | +119.9% | -15.1% | -18.0% | -18.4% | -20.0% | -19.6% | -16.9% |
Other intangible assets—net at Other Companies
Frequently Asked Questions
- What is Amgen's other intangible assets—net?
- Amgen (AMGN) reported other intangible assets—net of $21.38B in Q1 2026.
- How has Amgen's other intangible assets—net changed year-over-year?
- Amgen's other intangible assets—net decreased by 16.9% year-over-year, from $25.72B to $21.38B.
- What is the long-term trend for Amgen's other intangible assets—net?
- Over 5 years (2020 to 2025), Amgen's other intangible assets—net has grown at a 6.1% compound annual growth rate (CAGR), from $16.59B to $22.28B.
- What does other intangible assets—net mean?
- The value of non-physical assets like patents and intellectual property, excluding goodwill.